Market Overview

UBS: Baxalta Is A Buy Even If Shire Buyout Doesn't Happen

Share:
UBS: Baxalta Is A Buy Even If Shire Buyout Doesn't Happen
Related
Shire Down 6% Since Brexit, Goldman Sachs Still Bullish
The Market In 5 Minutes: Happy Memorial Day Weekend
Related
KemPharm CEO On Recent Results, Catalysts And Prospects: 'ADHD Is By Far The Larger Market Opportunity'
Here Are Some Of Leon Cooperman's Top Stock Picks For 2017
Pharma bigwigs acknowledge challenges with perceptions of pricing as Trump prepares to take office (Seeking Alpha)

Baxalta Inc (NYSE: BXLT) shares had a big Monday after a Bloomberg report of acquisition interest from Shire PLC (ADR) (NASDAQ: SHPG) hit wires over the weekend.

According to the report, Shire is in advanced talks to buy Baxalta for about $32 billion in cash and stock excluding debt -- a per share price between $46.50 and $48.

UBS analysts have since reacted to the rumor.

UBS Analyst: We Still Like Baxalta

In a note to subscribers, analyst Matt Miksic explained that it had been his firm's view since its coverage launch in September, "another offer was possible." Miksic's Buy rating on Baxalta is not contingent on a deal, he added.

The analyst also highlighted recent positive performance. "[S]ince declining to engage Shire on its initial offer in August, the company has beat Q3 estimates, raised guidance for 2015, guided to an above-consensus outlook for 2016 and obtained two key new pipeline approvals (Adynovate and Vonvendi.)"

UBS holds a Buy rating on Baxalta. In its initiation last Fall, the firm unveiled a $46 price target on the stock.

At that time, Miksic said its 100-patient UBS Evidence Lab US Haemophilia survey provided the "best feedback we've ever seen" on haemophilia A patients.

Latest Ratings for BXLT

DateFirmActionFromTo
Feb 2016UBSMaintainsBuy
Dec 2015BarclaysMaintainsEqual-Weight
Aug 2015William BlairInitiates Coverage onOutperform

View More Analyst Ratings for BXLT
View the Latest Analyst Ratings

Posted-In: Analyst Color Biotech Long Ideas News Top Stories Analyst Ratings Movers Trading Ideas Best of Benzinga

 

Related Articles (SHPG + BXLT)

View Comments and Join the Discussion!